Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Non Operating Investment Income: 2011-2012

Historic Non Operating Investment Income for Arrowhead Pharmaceuticals (ARWR) over the last 2 years, with Sep 2012 value amounting to -$58,091.

  • Arrowhead Pharmaceuticals' Non Operating Investment Income changed negligibly% to $62,954 in Q1 2014 from the same period last year, while for Mar 2014 it was $251,816, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of -$58,091 for FY2012, which is 77.76% up from last year.
  • Latest data reveals that Arrowhead Pharmaceuticals reported Non Operating Investment Income of -$58,091 as of FY2012, which was up 77.76% from -$261,219 recorded in FY2011.
  • In the past 5 years, Arrowhead Pharmaceuticals' Non Operating Investment Income ranged from a high of -$58,091 in FY2012 and a low of -$261,219 during FY2011.
  • Over the past 2 years, Arrowhead Pharmaceuticals' median Non Operating Investment Income value was -$159,655 (recorded in 2011), while the average stood at -$159,655.
  • Data for Arrowhead Pharmaceuticals' Non Operating Investment Income shows a peak YoY surged of 77.76% (in 2012) over the last 5 years.
  • Yearly analysis of 2 years shows Arrowhead Pharmaceuticals' Non Operating Investment Income stood at -$261,219 in 2011, then skyrocketed by 77.76% to -$58,091 in 2012.